Amir Lotfi to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Amir Lotfi has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.396
-
Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J. 2008 May; 155(5):954-8.
Score: 0.248
-
Daoulah A, Al-Faifi SM, Alhamid S, Youssef AA, Alshehri M, Al-Murayeh M, Farghali T, Maghrabi M, Balghith M, ElSayed O, Alasmari A, Arafat AA, Elmahrouk AF, Eldesoky A, Refaat WA, Alshahrani SS, Ghazi AM, Al-Azizi KM, Dahdouh Z, Lotfi A. Spontaneous Coronary Artery Dissection in the Gulf: G-SCAD Registry. Angiology. 2021 01; 72(1):32-43.
Score: 0.147